Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LASP1 neighbor protein (LASP1NB), also known as LINC00672 or Long intergenic non-protein coding RNA 672, is annotated as either a protein-coding gene or a long non-coding RNA, with current evidence pointing mainly to a lncRNA function[4][6]. It is located on chromosome 17 (17q12) and may play a key regulatory role in specific cellular contexts such as fibroblast–keratinocyte-like cell transitions[6]. LASP1NB has been associated with cancer biology, including a proposed role in p53-mediated gene suppression and increased chemosensitivity in endometrial cancer[4]. There are no approved drugs targeting LASP1NB directly, and its primary significance at present is as a potential biomarker or regulatory molecule rather than a conventional therapeutic target.
Not established; no known drugs directly targeting LASP1 neighbor protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LASP1 neighbor protein (LASP1NB).